Accelerating immuno-oncology innovation using humanized mouse models

Join us for this very exciting webinar where we discuss some of the most valuable immunology and oncology research tools available to date: humanized mouse models. Learn how these robust, translationally relevant mouse models are rapidly changing preclinical drug development in ways we never thought possible.

• Humanized components of the immune/oncology checkpoint pathways
• Models for bi-specific antibody development
• Next generation immunodeficient mice (NCG) for xenografts and better stem cell engraftment

Santi Suryani Chen PhD

Associate Director of Immuno-Oncology, GemPharmatech

Watch now

SPEAKERS

Santi Suryani Chen PhD

Associate Director of Immuno-Oncology, GemPharmatech

You might also like

Accelerating AAV process development with PAT-driven TFF system

Teva Smith

6 March

Watch

Accelerating AAV process development: NCSU BTEC

Shriarjun Shastry, Blaz Bakalar

8 October

Watch

Accelerating AAV production: optimizing compound identification and process parameters

Keara Sutherland, Jean-Marc Guedon

20 November

Watch

Efficient reprogramming of fibroblasts into iPSCs using mRNA technology

S Diecke, H Johannsen, P Nouri

5 December 2023

Watch

Alternative solutions to separate AAV full and empty capsids using anion exchange

Åsa Hagner-McWhirter, Mark Schofield

2 April

Watch